Success stories:
Diadema Farmaceutici & Tissuegraft S.r.l.
Diadema Farmaceutici is a certified innovative SME committed to the research and development of advanced therapeutic solutions in areas such as ophthalmology, gastroenterology and neurology. The company promotes innovation and improvements in the treatment experience for patients and physicians, collaborating with valuable partners to offer high quality products.
TissueGraft is a company that develops innovative solutions to aid tissue regeneration. It uses advanced technologies to create biocompatible materials that can be used in surgery and regenerative medicine, improving patient recovery. The aim is to facilitate soft tissue healing by offering safe and effective products.
Our support in the Joint Venture between Diadema Farmaceutici and Tissuegraft S.r.l.
Reaching the Joint Venture agreement was the result of a process of rapprochement and in-depth analysis that aligned the interests of the parties involved, fostering a strategic collaboration based on mutual trust and common goals of growth and development.
The architects of this partnership are several:
Creationimpresa gave impetus to the initiative, and in particular Dr. Nicola Vernaglione provided in-depth economic-financial analysis and high-level strategic advice to support the whole operation.
The legal teams of the two parties (Avv. Luigi Murciano and Avv. Giulio Vannucci for Diadema Farmaceutici and Avv. Andrea Lovato for Tissuegraft S.r.l.) defined the contractual aspects, while Diadema’s high-calibre scientific committee tested the project’s great potential.
The expertise and vision of the management of the companies involved, in particular Camillo Bisoglio and Francesca Boccafoschi for Tissuegraft S.r.l.and Mario Bianchi and Giammario Piras for Diadema Farmaceutici, were decisive for the success of this partnership.
Pierpaolo Vannucci Advisors successfully supported the joint venture, providing strategic and financial advice to facilitate the integration of the two companies. Thanks to our experience in the innovative SME sector, we helped create a solid and profitable partnership aimed at developing advanced solutions in the field of regenerative medicine.
